Comparison 5. Adverse effects of live attenuated vaccine (intranasal) versus trivalent inactivated vaccine (intramuscular).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Subjects reporting wheeze in the first 15 days | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Subjects reporting runny nose or nasal congestion in the first 15 days | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
3 Subjects reporting bronchospasm as an adverse event in first 15 days | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
4 Subjects reporting rhinitis as an adverse event in the first 15 days | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | Totals not selected |